Tehran University of Medical Sciences

Science Communicator Platform

Share By
Spatial Distribution of Common Pathogenic Human Intestinal Protozoa in Iran: A Systematic Review Publisher



Mohebali M1, 2 ; Keshavarz H1, 2 ; Abbaszadeh Afshar MJ2 ; Hanafibojd AA3 ; Hassanpour G1, 2
Authors

Source: Iranian Journal of Public Health Published:2021


Abstract

Background: Pathogenic intestinal protozoa are considered as a serious public health problem in developing countries. This study aimed to elucidate the overall prevalence and spatial distribution of three common human pathogenic intestinal protozoan infections in Iran. Methods: Six English and Persian databases were explored for published papers on the prevalence of Entamoeba histolytica/dispar, Giardia lamblia, and Cryptosporidium spp. in the general population of Iran from 2000 to 2015. All eligible data were collected using a pre-designed data extraction form, and the overall prevalence was estimated using a random-effects meta-analysis model. We used ArcMap for mapping the prevalence of the studied protozoa and clustering analysis. Results: Altogether, 118 eligible papers from 24 provinces of Iran were included and analyzed. The weighted prevalence of E. histolytica/dispar, G. lamblia, and Cryptosporidium spp. infection among Iranian general population were calculated 1.3% (95% CI 1.1-1.5%), 10.6% (95% CI 9.6-11.5%) and 2% (95% CI 1.5-2.5%), respectively. Conclusion: Our findings indicated human intestinal protozoan infections caused by E. histolytica/dispar, G. lamblia, and Cryptosporidium spp. have still public health importance in some parts of Iran. © 2021, Iranian Journal of Public Health. All rights reserved.
Other Related Docs
9. Emerging and Re-Emerging Infectious Diseases in Iran, Iranian Journal of Microbiology (2017)
17. Mapping and Review of Leishmaniasis, Its Vectors and Main Reservoirs in Iran, Journal of Kerman University of Medical Sciences (2015)
19. Human Cysticercosis in Asia: A Systematic Review and Meta-Analysis, Iranian Journal of Public Health (2020)